Sands Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.4M Buy
45,332
+12,445
+38% +$12.7M 0.2% 52
2026
Q1
$30.2M Buy
+32,887
New +$33.3M 0.12% 50

Other funds holding LLY

Sands Capital Management's LLY Position: Q2 2026 in Review

Sands Capital Management increased its Eli Lilly (LLY) stake by 38% in Q2 2026, buying an estimated $12.7M and bringing the position to 45,332 shares worth $54.4M. The position accounts for 0.2% of the portfolio, ranked #52.

Sands Capital Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sands Capital Management held 45,332 shares of Eli Lilly worth $54.4M as of Q2 2026.
  • Sands Capital Management bought 12,445 Eli Lilly shares in Q2 2026, an estimated $12.7M.
  • Eli Lilly made up 0.2% of Sands Capital Management's portfolio in Q2 2026, its #52 holding.
  • Sands Capital Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sands Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.